Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 27, 2023

Investigational Drug Information for Linifanib

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the development status for investigational drug Linifanib?

Linifanib is an investigational drug.

There have been 12 clinical trials for Linifanib. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1^st 2010.

The most common disease conditions in clinical trials are Neoplasms, Carcinoma, Hepatocellular, and Carcinoma. The leading clinical trial sponsors are Abbott, AbbVie, and Sir Salimullah Medical College Mitford Hospital.

Summary for Linifanib

US Patents	0
International Patents	0
US Patent Applications	1,667
WIPO Patent Applications	1,169
Japanese Patent Applications	636
Clinical Trial Progress	Phase 1 (2010-01-01)
Vendors	101

Recent Clinical Trials for Linifanib

Title	Sponsor	Phase
Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma	Sir Salimullah Medical College Mitford Hospital	N/A
Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis	BioGene Pharmaceutical Ltd.	Phase 1/Phase 2
A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors	Abbott	Phase 1

See all Linifanib clinical trials

Clinical Trial Summary for Linifanib

Top disease conditions for Linifanib

Top clinical trial sponsors for Linifanib

See all Linifanib clinical trials

US Patents for Linifanib

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Mallinckrodt

Medtronic

AstraZeneca

Express Scripts

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.